Hainan Shuangcheng Pharmaceut Cash Flow Conversion Efficiency
Hainan Shuangcheng Pharmaceut cash flow conversion efficiency. Based on the latest financial reports, Hainan Shuangcheng Pharmaceut (002693) has a cash flow conversion efficiency ratio of 0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥33.67 Million ≈ $4.93 Million USD) by net assets (CN¥404.35 Million ≈ $59.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Hainan Shuangcheng Pharmaceut (2009–2025)
Cash flow conversion efficiency of Hainan Shuangcheng Pharmaceut from 2009 to 2025. This chart illustrates how Hainan Shuangcheng Pharmaceut's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002693 stock price for real-time trading data and today's change.
Hainan Shuangcheng Pharmaceut Cash Flow Conversion Ratio Explained
Hainan Shuangcheng Pharmaceut cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Hainan Shuangcheng Pharmaceut Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hainan Shuangcheng Pharmaceut ranked by their cash flow conversion efficiency. Also see Hainan Shuangcheng Pharmaceut market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Water Planning & Design Institute Co. Ltd.
SHE:301038
|
N/A |
|
St Barbara Limited
F:BM1
|
0.008x |
|
Xilinmen Furniture Co Ltd
SHG:603008
|
0.044x |
|
Well Lead Med Co Ltd
SHG:603309
|
0.071x |
|
Hailir Pesticides and Chemicals Group Co Ltd
SHG:603639
|
0.047x |
|
CapitaLand Malaysia Mall Trust
KLSE:5180
|
0.021x |
|
Jee Technology Co. Ltd. A
SHG:688162
|
N/A |
|
Aarti Drugs Limited
NSE:AARTIDRUGS
|
0.098x |
Annual Cash Flow Conversion Efficiency for Hainan Shuangcheng Pharmaceut (2009–2025)
The table below shows the annual cash flow conversion efficiency of Hainan Shuangcheng Pharmaceut from 2009 to 2025. Review how much free cash does Hainan Shuangcheng Pharmaceut generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥420.53 Million ≈ $61.54 Million |
CN¥60.95 Million ≈ $8.92 Million |
0.145x | +246.12% |
| 2024-12-31 | CN¥411.61 Million ≈ $60.23 Million |
CN¥-40.83 Million ≈ $-5.97 Million |
-0.099x | -541.12% |
| 2023-12-31 | CN¥517.65 Million ≈ $75.75 Million |
CN¥11.64 Million ≈ $1.70 Million |
0.022x | -48.20% |
| 2022-12-31 | CN¥580.94 Million ≈ $85.01 Million |
CN¥25.22 Million ≈ $3.69 Million |
0.043x | +4.45% |
| 2021-12-31 | CN¥566.75 Million ≈ $82.93 Million |
CN¥23.55 Million ≈ $3.45 Million |
0.042x | +336.77% |
| 2020-12-31 | CN¥598.31 Million ≈ $87.55 Million |
CN¥-10.50 Million ≈ $-1.54 Million |
-0.018x | -117.88% |
| 2019-12-31 | CN¥678.26 Million ≈ $99.25 Million |
CN¥66.58 Million ≈ $9.74 Million |
0.098x | +40.36% |
| 2018-12-31 | CN¥669.69 Million ≈ $98.00 Million |
CN¥46.84 Million ≈ $6.85 Million |
0.070x | +336.39% |
| 2017-12-31 | CN¥761.71 Million ≈ $111.46 Million |
CN¥-22.54 Million ≈ $-3.30 Million |
-0.030x | -142.35% |
| 2016-12-31 | CN¥553.13 Million ≈ $80.94 Million |
CN¥38.65 Million ≈ $5.66 Million |
0.070x | +40.17% |
| 2015-12-31 | CN¥927.61 Million ≈ $135.74 Million |
CN¥46.24 Million ≈ $6.77 Million |
0.050x | -12.67% |
| 2014-12-31 | CN¥893.55 Million ≈ $130.75 Million |
CN¥51.00 Million ≈ $7.46 Million |
0.057x | -11.95% |
| 2013-12-31 | CN¥870.62 Million ≈ $127.40 Million |
CN¥56.43 Million ≈ $8.26 Million |
0.065x | -31.65% |
| 2012-12-31 | CN¥845.85 Million ≈ $123.77 Million |
CN¥80.22 Million ≈ $11.74 Million |
0.095x | -67.23% |
| 2011-12-31 | CN¥228.23 Million ≈ $33.40 Million |
CN¥66.05 Million ≈ $9.67 Million |
0.289x | -17.45% |
| 2010-12-31 | CN¥157.82 Million ≈ $23.09 Million |
CN¥55.33 Million ≈ $8.10 Million |
0.351x | -38.27% |
| 2009-12-31 | CN¥77.95 Million ≈ $11.41 Million |
CN¥44.27 Million ≈ $6.48 Million |
0.568x | -- |
About Hainan Shuangcheng Pharmaceut
Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical injections, solid preparations, and raw materials in China and internationally. The company offers products for oncology and immune, alimentary canal, heart and cerebral, and vessels and metabolism. It also provides Bivalirudin, Epitifibatide, and Thymalfaxin for injection; Pre… Read more